Literature DB >> 9712809

Antibody responses in humans against coli surface antigen 6 of enterotoxigenic Escherichia coli.

A Helander1, C Wennerås, F Qadri, A M Svennerholm.   

Abstract

Enterotoxigenic Escherichia coli (ETEC) strains expressing only coli surface antigen 6 (CS6) have previously been isolated from patients with diarrhea, but the immunogenicity of CS6 has not been established in humans. We have detected CS6-specific immunoglobulin A responses in the feces and blood of patients convalescing from natural ETEC disease and of volunteers given an oral ETEC vaccine.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9712809      PMCID： PMC108547          DOI： 10.1128/IAI.66.9.4507-4510.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  19 in total

1.  Safety and immunogenicity of the live oral auxotrophic Shigella flexneri SFL124 in volunteers.

Authors:  A Li; T Pál; U Forsum; A A Lindberg
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Characterization of a putative colonization factor (PCFO166) of enterotoxigenic Escherichia coli of serogroup O166.

Authors:  M M McConnell; H Chart; A M Field; M Hibberd; B Rowe
Journal:  J Gen Microbiol       Date:  1989-05

3.  Genetic control and properties of coli surface antigens of colonization factor antigen IV (PCF8775) of enterotoxigenic Escherichia coli.

Authors:  M M McConnell; L V Thomas; G A Willshaw; H R Smith; B Rowe
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

4.  Monoclonal antibodies against different epitopes on colonization factor antigen I of enterotoxin-producing Escherichia coli.

Authors:  Y Lopez-Vidal; P Klemm; A M Svennerholm
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

5.  Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

Authors:  A M Svennerholm; M Jertborn; L Gothefors; A M Karim; D A Sack; J Holmgren
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

6.  Monoclonal antibodies against the different subcomponents of colonization factor antigen II of enterotoxigenic Escherichia coli.

Authors:  Y Lopez-Vidal; A M Svennerholm
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

7.  Colonization factors of enterotoxigenic Escherichia coli isolated from children with diarrhea in Argentina.

Authors:  N Binsztein; M J Jouve; G I Viboud; L López Moral; M Rivas; I Orskov; C Ahrén; A M Svennerholm
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

8.  Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine.

Authors:  C Ahrén; C Wennerås; J Holmgren; A M Svennerholm
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

9.  Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East.

Authors:  M K Wolf; D N Taylor; E C Boedeker; K C Hyams; D R Maneval; M M Levine; K Tamura; R A Wilson; P Echeverria
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

10.  Local and systemic antibody responses to naturally acquired enterotoxigenic Escherichia coli diarrhea in an endemic area.

Authors:  B J Stoll; A M Svennerholm; L Gothefors; D Barua; S Huda; J Holmgren
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226
View more
  4 in total

1.  Mucosal and systemic immune responses in patients with diarrhea due to CS6-expressing enterotoxigenic Escherichia coli.

Authors:  Firdausi Qadri; Tanvir Ahmed; Firoz Ahmed; M Saruar Bhuiyan; Mohammad Golam Mostofa; Frederick J Cassels; Anna Helander; Ann-Mari Svennerholm
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

2.  Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.

Authors:  T S Coster; M K Wolf; E R Hall; F J Cassels; D N Taylor; C T Liu; F C Trespalacios; A DeLorimier; D R Angleberger; C E McQueen
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

3.  Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.

Authors:  Fernando Güereña-Burgueño; Eric R Hall; David N Taylor; Frederick J Cassels; Daniel A Scott; Marcia K Wolf; Zachary J Roberts; Galina V Nesterova; Carl R Alving; Gregory M Glenn
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Colonization factor CS30 from enterotoxigenic Escherichia coli binds to sulfatide in human and porcine small intestine.

Authors:  Astrid Von Mentzer; Dani Zalem; Zofia Chrienova; Susann Teneberg
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.